메뉴 건너뛰기




Volumn 20, Issue 2, 2012, Pages 185-190

Rhabdoid carcinoma of the colon: A distinct entity with a very aggressive behavior: A case report associated with a polyposis coli and review of the literature

Author keywords

carcinosarcoma; colon adenocarcinoma; malignant extrarenal tumor; rhabdoid tumor; sarcomatoid carcinoma

Indexed keywords

B RAF KINASE; K RAS PROTEIN; NEUROGENIN 1; PROTEIN MLH1; PROTEIN MSH2; SOMATOMEDIN BINDING PROTEIN 2; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR RUNX3;

EID: 84860157478     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896911415405     Document Type: Review
Times cited : (22)

References (13)
  • 1
  • 3
    • 0029923967 scopus 로고    scopus 로고
    • Malignant rhabdoid tumor of the colon: Report of a case with molecular analysis
    • Marcus VA, Viloria J, Owen D, Tsao MS. Malignant rhabdoid tumor of the colon: report of a case with molecular analysis. Dis Colon Rectum. 1996 ; 39: 1322-1326 (Pubitemid 26389548)
    • (1996) Diseases of the Colon and Rectum , vol.39 , Issue.11 , pp. 1322-1326
    • Marcus, V.A.1    Viloria, J.2    Owen, D.3    Tsao, M.-S.4
  • 5
    • 0028228789 scopus 로고
    • Malignant rhabdoid tumour of the colon
    • Yang AH, Chen WYK, Chiang H. Malignant rhabdoid tumour of the colon. Histopatholgy. 1994 ; 24: 89-91
    • (1994) Histopatholgy , vol.24 , pp. 89-91
    • Yang, A.H.1    Wyk, C.2    Chiang, H.3
  • 6
    • 79959337448 scopus 로고    scopus 로고
    • A novel case of rhabdoid colon carcinoma associated with a CpG island methylator phenotype-positive phenotype and BRAF mutation
    • Pancione M, Di Blasi A, Sabatino L, et al. A novel case of rhabdoid colon carcinoma associated with a CpG island methylator phenotype-positive phenotype and BRAF mutation. Hum Pathol. 2011 ; 42: 1047-1052
    • (2011) Hum Pathol , vol.42 , pp. 1047-1052
    • Pancione, M.1    Di Blasi, A.2    Sabatino, L.3
  • 8
    • 0029165893 scopus 로고
    • Malignant rhabdoid tumors: A clinicopathologic review and conceptual discussion
    • Wick MR, Ritter JH, Dehner LP. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion. Semin Diagn Pathol. 1995 ; 12: 233-248
    • (1995) Semin Diagn Pathol , vol.12 , pp. 233-248
    • Wick, M.R.1    Ritter, J.H.2    Dehner, L.P.3
  • 9
    • 1642535480 scopus 로고    scopus 로고
    • BRAF Mutation Is Frequently Present in Sporadic Colorectal Cancer with Methylated hMLH1, but Not in Hereditary Nonpolyposis Colorectal Cancer
    • DOI 10.1158/1078-0432.CCR-1118-3
    • Deng G, Bell I, Crawley S, et al. BRAF mutation is frequently present 359 in sporadic colorectal cancer with methylated hMLH1, but not in 360 hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004 ; 10 (1). 191-195 (Pubitemid 38114179)
    • (2004) Clinical Cancer Research , vol.10 , Issue.1 , pp. 191-195
    • Deng, G.1    Bell, I.2    Crawley, S.3    Gum, J.4    Terdiman, J.P.5    Allen, B.A.6    Truta, B.7    Sleisenger, M.H.8    Kim, Y.S.9
  • 10
    • 58149147370 scopus 로고    scopus 로고
    • Colon cancer: It's CIN or CIMP
    • Issa JP. Colon cancer: It's CIN or CIMP. Clin Cancer Res. 2008 ; 14: 5939-5940
    • (2008) Clin Cancer Res , vol.14 , pp. 5939-5940
    • Issa, J.P.1
  • 11
    • 54449092791 scopus 로고    scopus 로고
    • CpG island methylator phenotype in 349 colorectal cancers: Comparison of the new and classic CpG island 350 methylator phenotype marker panels
    • Lee S, Cho NY, Yoo EJ, Kim JH, Kang GH. CpG island methylator phenotype in 349 colorectal cancers: comparison of the new and classic CpG island 350 methylator phenotype marker panels. Arch Pathol Lab Med. 2008 ; 132: 1657-1665
    • (2008) Arch Pathol Lab Med , vol.132 , pp. 1657-1665
    • Lee, S.1    Cho, N.Y.2    Yoo, E.J.3    Kim, J.H.4    Kang, G.H.5
  • 12
    • 77954346705 scopus 로고    scopus 로고
    • Clinical practice guidelines. Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
    • Van Cutsem E, Nordlinger B, Cervantes A. Clinical practice guidelines. Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Ann Oncol. 2010 ; 21 (suppl 5). v93 - v97
    • (2010) Ann Oncol , vol.21 , Issue.SUPPL. 5
    • Van Cutsem, E.1    Nordlinger, B.2    Cervantes, A.3
  • 13
    • 54249098184 scopus 로고    scopus 로고
    • KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: Proposal for a European quality assurance program
    • van Krieken JH, Jung A, Kirchner T, et al. KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for a European quality assurance program. Virchows Arch. 2008 ; 453: 417-431
    • (2008) Virchows Arch , vol.453 , pp. 417-431
    • Van Krieken, J.H.1    Jung, A.2    Kirchner, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.